Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Regenxbio Inc shares valued at $254,310 were purchased by CURRAN M SIMPSON on Oct 09 ’25. At $12.22 per share, CURRAN M SIMPSON acquired 20,811 shares.
Also, Simpson Curran sold 7,624 shares, netting a total of over 76,469 in proceeds. Following the sale of shares at $10.03 each, the insider now holds 236,973 shares.
Before that, Simpson Curran had sold 7,734 shares from its account. In a trade valued at $77,495, the Chief Executive Officer traded Regenxbio Inc shares for $10.02 each. Upon closing the transaction, the insider’s holdings decreased to 7,734 shares, worth approximately $2.98 million.
As published in a research note from Goldman on February 11, 2025, Regenxbio Inc [RGNX] has been rated down from a Buy to a Neutral and the price target has been revised to $14 from $38.
Analyzing RGNX Stock Performance
On last trading session, Regenxbio Inc [NASDAQ: RGNX] plunged -0.41% to $12.17. The stock’s lowest price that day was $12.1594, but it reached a high of $12.805 in the same session. During the last five days, there has been a surge of approximately 15.03%. Over the course of the year, Regenxbio Inc shares have jumped approximately 27.84%. Shares of the company reached a 52-week high of $12.84 on 10/09/25 and a 52-week low of $5.03 on 04/09/25.
Support And Resistance Levels for Regenxbio Inc (RGNX)
According to the 24-hour chart, there is a support level at 11.93, which, if violated, would cause prices to drop to 11.70. In the upper region, resistance lies at 12.62. The next price resistance is at 13.08. RSI (Relative Strength Index) is 73.65 on the 14-day chart, showing overbought technical sentiment.
Is Regenxbio Inc subject to short interest?
Stocks of Regenxbio Inc saw a sharp steep in short interest on 2025-09-15 dropping by -0.4 million shares to 5.07 million. Data from Yahoo Finance shows that the short interest on 2025-08-15 was 5.47 million shares. A decline of -7.97% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 9.24 of the overall float, the days-to-cover ratio (short ratio) decline to 9.24.
Which companies own the most shares of Regenxbio Inc (RGNX)?
In terms of Regenxbio Inc share price expectations, FactSet research, analysts set an average price target of 30 in the next 12 months, up nearly 145.5% from the previous closing price of $12.22. Analysts anticipate Regenxbio Inc stock to reach 40 by 2025, with the lowest price target being 18. In spite of this, 6 analysts ranked Regenxbio Inc stock as Buy at the end of 2025. On June 07, 2024, Goldman assigned a price target of “a Buy” to the stock and initiated coverage with a $38.
